Semaglutide

Semaglutide is a GLP-1 receptor agonist, a medication that mimics a naturally occurring hormone involved in appetite, fullness, glucose regulation, and digestion. For appropriate patients, semaglutide can reduce hunger and make it easier to maintain a lower calorie intake over time. At Fountain, medication is combined with attention to nutrition, physical activity, muscle preservation, sleep, body composition, and metabolic health. The goal is not simply to suppress appetite. It is to use the medication as part of a sustainable plan for improving weight and overall health.

Weight loss with semaglutide can include both body fat and lean tissue, which is why the number on the scale does not tell the whole story. Fountain pays attention to body composition, protein intake, resistance training, nutrition, and physical function throughout treatment. Depending on the patient, body-composition testing and support from nutrition and fitness specialists can help determine whether weight loss is occurring in a healthy way. The goal is not simply to lose as much weight as possible. It is to reduce excess body fat while preserving muscle, strength, and metabolic health as much as possible.

Response varies considerably from person to person. Some patients notice reduced hunger or earlier fullness relatively soon, while others do not experience a major difference at the initial dose. Because semaglutide is generally increased gradually, the first few weeks do not necessarily predict your eventual response. Fountain focuses on the trend over time, including appetite, weight, body composition, nutrition, side effects, and metabolic health, rather than judging treatment based on the first few doses.

There is no required “semaglutide diet.” In fact, because appetite may decrease significantly, one of the priorities is making sure you continue to receive adequate nutrition. Your plan may focus on sufficient protein to support muscle, fiber-containing foods, hydration, micronutrients, and an appropriate balance of carbohydrates and fats based on your health and goals. Smaller meals may also be easier to tolerate for some patients. Fountain incorporates nutrition support into its medically supervised GLP-1 program rather than treating the medication as a substitute for nutrition.

The most common side effects are gastrointestinal and can include nausea, constipation, diarrhea, abdominal discomfort, reduced appetite, and vomiting. Some symptoms may improve as your body adjusts. However, persistent vomiting, severe abdominal pain, inability to maintain hydration, or other significant or unusual symptoms should be discussed promptly with your care team. Fountain uses gradual dose progression and ongoing monitoring rather than increasing the dose simply to accelerate weight loss.

Semaglutide at Fountain is part of a medically supervised weight-management program rather than a prescription-only service. Fountain’s GLP-1 protocol includes gradual titration, regular clinical follow-up, baseline laboratory testing with repeat labs when appropriate, baseline and follow-up body-composition assessment, nutrition support, and ongoing monitoring throughout treatment. We look at more than body weight. Depending on your goals, that can include body composition, nutrition, muscle preservation, metabolic markers, side effects, appetite, energy, and physical function so the treatment can evolve as your health changes.